Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Sucralfate: the Bangkok review

M G Korman1, T D Bolin, S Szabo

  • 1Monash Medical Centre, Clayton, Victoria, Australia.

Journal of Gastroenterology and Hepatology
|July 1, 1994
PubMed
Summary

Sucralfate enhances ulcer healing by binding and delivering growth factors, improving tissue repair and reducing relapse rates. This site-protective drug offers a safe and effective option for various gastrointestinal conditions.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tissue-resident memory T cells are epigenetically cytotoxic with signs of exhaustion in human urinary bladder cancer.

Clinical and experimental immunology·2018
Same author

The enteric nervous system in health and disease.

Gut·2008
Same author

The treatment of peptic ulcer disease.

Current opinion in gastroenterology·2006
Same author

The medical treatment of peptic ulcer disease.

Current opinion in gastroenterology·2006
Same author

The treatment of peptic ulcer disease.

Current opinion in gastroenterology·2006
Same author

Cyanoacrylate in the treatment of gastric varices complicated by multiple pulmonary emboli.

Internal medicine journal·2006

Area of Science:

  • Gastroenterology
  • Pharmacology

Background:

  • Sucralfate is a well-established cytoprotective agent for ulcer healing.
  • Its mechanisms of action extend beyond simple mucosal protection.

Purpose of the Study:

  • To elucidate the multifaceted mechanisms of sucralfate in promoting ulcer healing.
  • To highlight sucralfate's role in improving healing quality and reducing relapse rates.

Main Methods:

  • Review of recent studies on sucralfate's interactions with growth factors.
  • Analysis of clinical data on sucralfate's efficacy and safety in various gastrointestinal conditions.

Main Results:

  • Sucralfate binds basic fibroblast growth factor (bFGF), concentrating it at ulcer sites.
  • bFGF promotes granulation tissue formation, angiogenesis, and re-epithelialization, enhancing healing quality.

Related Experiment Videos

  • Sucralfate may reduce parietal cell sensitivity, contributing to lower duodenal ulcer relapse rates.
  • Efficacious in healing duodenal/gastric ulcers and mild esophagitis; safe for short-term and maintenance use.
  • Effective for stress ulcer prophylaxis with lower rates of nosocomial pneumonia compared to acid suppressors.

    • Conclusions:

    • Sucralfate offers superior ulcer healing quality and potentially longer remission durations.
    • Its unique mechanism involving growth factor delivery presents a significant advantage in gastrointestinal therapy.